RxDoctor Payments Data

Audrey Wedde, DO

Family Medicine · Buchanan, MINPI 1457743486

Payments from drug & device makers

$9,429in general payments, 2019–2025

Across 589 payments — averaging $16.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • Amgen$784
  • Boehringer Ingelheim$769
  • GSK$661
  • AstraZeneca$595
  • plus $4K from 36 others

What the payments were for

  • Food & beverage$9,429100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,429 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$51,797
Medicare patients
160
Services billed
535

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$63,588
JardianceEmpagliflozin51$60,942
FarxigaDapagliflozin Propanediol38$48,516
EliquisApixaban47$45,775
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$39,916
TrulicityDulaglutide16$36,052
XareltoRivaroxaban31$33,599
MounjaroTirzepatide22$28,575
JanuviaSitagliptin Phosphate16$13,895
MyrbetriqMirabegron17$12,671
Tresiba Flextouch U-100Insulin Degludec11$5,142
Gabapentin156$2,851
Atorvastatin Calcium271$2,761
Levothyroxine Sodium226$2,740
Albuterol Sulfate HfaAlbuterol Sulfate69$2,478

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$585$64,62738 claims
Novo NordiskOzempic$1,251$63,58836 claims
Boehringer IngelheimJardiance$769$60,94251 claims
AstraZenecaFarxiga$595$48,51638 claims
PfizerEliquis$283$45,77547 claims
GSKTrelegy Ellipta$661$39,91646 claims
Johnson & JohnsonXarelto$235$33,59931 claims
MerckJanuvia$465$13,89516 claims
Astellas Pharma US IncMyrbetriq$156$12,67117 claims
Sanofi-aventis U.S. LLCLantus$271$90513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Buchanan

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →